• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Quanterix Corporation - Common Stock (NQ:QTRX)

    7.950 +0.600 (+8.16%)
    Official Closing Price Updated: 4:15 PM EST, Jan 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 612,194
    Open 7.330
    Bid (Size) 7.070 (200)
    Ask (Size) 8.500 (200)
    Prev. Close 7.350
    Today's Range 7.250 - 7.970
    52wk Range 4.050 - 10.28
    Shares Outstanding 38,063,618
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    What's going on in today's session ↗
    Via Chartmill
    Keep an eye on the top gainers and losers in Friday's session. ↗
    Via Chartmill

    Performance

    YTD
    +23.6%
    +23.6%
    1 Month
    +8.0%
    +8.0%
    3 Month
    +33.6%
    +33.6%
    6 Month
    +44.3%
    +44.3%
    1 Year
    -7.8%
    -7.8%

    More News

    Read More
    News headline image
    Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix Announces Landmark Nature Study Redefining Alzheimer’s Disease Neuropathology Prevalence
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Earnings Scheduled For November 10, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Preview For Quanterix ↗
    Via Benzinga
    News headline image
    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix Releases Financial Results for the Third Quarter of 2025
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Earnings Scheduled For August 7, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Preview: Quanterix ↗
    Via Benzinga
    News headline image
    Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025
    From Quanterix
    Via Business Wire
    News headline image
    The Silent Architects: How Institutional Investors Shape Stock Performance and Market Destiny
    Via MarketMinute
    Topics Artificial Intelligence Bankruptcy Economy
    News headline image
    Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix Releases Financial Results for the Second Quarter of 2025
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix Announces Cooperation Agreement with Kent Lake Capital
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC
    From Quanterix Corporation
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    News headline image
    Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix Expands Reach with IVD and Large Reference Labs
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix to Present at Goldman Sachs Global Healthcare Conference
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix Releases Financial Results for the First Quarter of 2025
    From Quanterix Corporation
    Via Business Wire

    Frequently Asked Questions

    Is Quanterix Corporation - Common Stock publicly traded?
    Yes, Quanterix Corporation - Common Stock is publicly traded.
    What exchange does Quanterix Corporation - Common Stock trade on?
    Quanterix Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Quanterix Corporation - Common Stock?
    The ticker symbol for Quanterix Corporation - Common Stock is QTRX on the Nasdaq Stock Market
    What is the current price of Quanterix Corporation - Common Stock?
    The current price of Quanterix Corporation - Common Stock is 7.950
    When was Quanterix Corporation - Common Stock last traded?
    The last trade of Quanterix Corporation - Common Stock was at 01/15/26 04:15 PM ET
    What is the market capitalization of Quanterix Corporation - Common Stock?
    The market capitalization of Quanterix Corporation - Common Stock is 302.61M
    How many shares of Quanterix Corporation - Common Stock are outstanding?
    Quanterix Corporation - Common Stock has 303M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.